End organ failure
Data regarding end-organ failure are presented in Table 3. Significantly more renal failure requiring dialysis was observed in the ECMO+Impella® group (72% vs. 21%, p=0.09). Stroke rates did not show significant differences between the groups (ECMO 21% vs. ECMO+Impella® 29%, p=0.82). Subsequent limb ischemia occurred in 6 cases in the ECMO group and 1 in the ECMO+Impella® group (p=0.92).